Infused CD34+ cell dose predicts long-term survival in acute myelogenous leukemia patients who received allogeneic bone marrow transplantation from matched sibling donors in first complete remission
Open Access
- 1 February 2005
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 11 (2) , 122-128
- https://doi.org/10.1016/j.bbmt.2004.11.018
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrowBlood, 2003
- Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic CancersNew England Journal of Medicine, 2001
- No impact of high‐dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remissionBritish Journal of Haematology, 2000
- Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 1998
- Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemiaBone Marrow Transplantation, 1997
- A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemiaBritish Journal of Haematology, 1996
- Allogeneic bone marrow transplantation for acute nonlymphocytic leukemia in first remissionBlood, 1988
- Allogenic bone marrow transplantation: current status and future directionsBlood, 1983
- Bone Marrow Transplantation for Acute Myelogenous LeukemiaPublished by American Medical Association (AMA) ,1983
- Marrow Transplantation for Treatment of Aplastic AnemiaNew England Journal of Medicine, 1977